AQR Capital Management
VTYX

AQR Capital Management’s Ventyx Biosciences VTYX Stock Holding History

AQR Capital Management’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,768
Closed -$233K – 3826
2025
Q4 		$233K Sell
25,768
-157,673
-86% -$1.18M ﹤0.01% 3293
2025
Q3 		$571K Sell
183,441
-546,412
-75% -$1.45M ﹤0.01% 2750
2025
Q2 		$1.56M Sell
729,853
-150,369
-17% -$243K ﹤0.01% 1935
2025
Q1 		$1.01M Buy
880,222
+794,401
+926% +$1.36M ﹤0.01% 2009
2024
Q4 		$188K Sell
85,821
-22,940
-21% -$52K ﹤0.01% 2682
2024
Q3 		$237K Buy
108,761
+52,210
+92% +$120K ﹤0.01% 2495
2024
Q2 		$131K Buy
+56,551
New +$235K ﹤0.01% 2472
2023
Q4 		– Sell
-7,829
Closed -$272K – 2453
2023
Q3 		$272K Sell
7,829
-2,322
-23% -$80.3K ﹤0.01% 2038
2023
Q2 		$333K Sell
10,151
-617
-6% -$21.3K ﹤0.01% 1908
2023
Q1 		$361K Buy
+10,768
New +$419K ﹤0.01% 1882

Other funds holding VTYX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AQR Capital Management's VTYX Position: Q1 2026 in Review

AQR Capital Management sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 25,768 shares — an estimated $233K sold.

AQR Capital Management first reported a position in VTYX in Q1 2023 and held it in 10 quarters. The position peaked at $1.56M in Q2 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • AQR Capital Management reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • AQR Capital Management sold 25,768 Ventyx Biosciences shares in Q1 2026, an estimated $233K.
  • AQR Capital Management first reported a position in Ventyx Biosciences in Q1 2023 and held it in 10 quarters.
  • AQR Capital Management's Ventyx Biosciences position peaked at $1.56M in Q2 2025.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.